134 related articles for article (PubMed ID: 22921316)
21. Characterization of nucleosome positioning in hepadnaviral covalently closed circular DNA minichromosomes.
Shi L; Li S; Shen F; Li H; Qian S; Lee DH; Wu JZ; Yang W
J Virol; 2012 Sep; 86(18):10059-69. PubMed ID: 22787202
[TBL] [Abstract][Full Text] [Related]
22. Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virus.
Welschinger R; Cossart Y; Pouliopoulos J; Dixon R; Vickery K
J Viral Hepat; 2006 Aug; 13(8):515-22. PubMed ID: 16901281
[TBL] [Abstract][Full Text] [Related]
23. Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection.
Rollier C; Charollois C; Jamard C; Trepo C; Cova L
J Virol; 2000 May; 74(10):4908-11. PubMed ID: 10775634
[TBL] [Abstract][Full Text] [Related]
24. Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning.
Chassot S; Lambert V; Kay A; Godinot C; Trepo C; Cova L
Virology; 1994 Apr; 200(1):72-8. PubMed ID: 7510440
[TBL] [Abstract][Full Text] [Related]
25. Cloning, expression and purification of duck hepatitis B virus (DHBV) core protein and its use in the development of an indirect ELISA for serologic detection of DHBV infection.
Liu Q; Jia R; Wang M; Huang J; Zhu D; Chen S; Yin Z; Wang Y; Chen X; Cheng A
Arch Virol; 2014 May; 159(5):897-904. PubMed ID: 24158348
[TBL] [Abstract][Full Text] [Related]
26. Single B or T-cell epitope-based DNA vaccine using modified vector induces specific immune response against hepadnavirus.
Xu HB; Xu W; Chu YW; Wang Y; Xiong S
Immunol Lett; 2005 Jul; 99(2):186-92. PubMed ID: 16009269
[TBL] [Abstract][Full Text] [Related]
27. Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.
Le Guerhier F; Thermet A; Guerret S; Chevallier M; Jamard C; Gibbs CS; Trépo C; Cova L; Zoulim F
J Hepatol; 2003 Mar; 38(3):328-34. PubMed ID: 12586299
[TBL] [Abstract][Full Text] [Related]
28. Elimination of immune tolerance to hepatitis virus in an animal model.
Wen YM; Zhang W; Xu YY; Luo YF; Li PY
Chin Med J (Engl); 1992 Mar; 105(3):199-203. PubMed ID: 1395838
[TBL] [Abstract][Full Text] [Related]
29. [The effect of ribozyme RzDS on duck hepatitis B virus].
Li H; Chen W; Xu W
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):118-21. PubMed ID: 12515186
[TBL] [Abstract][Full Text] [Related]
30. Delipidation of a hepadnavirus: Viral inactivation and vaccine development.
Cham BE; Vickery K; Tohidi-Esfahani R; Cossart Y
J Virol Methods; 2006 Oct; 137(1):160-3. PubMed ID: 16808980
[TBL] [Abstract][Full Text] [Related]
31. Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.
Thermet A; Robaczewska M; Rollier C; Hantz O; Trepo C; Deleage G; Cova L
J Virol; 2004 Feb; 78(4):1945-53. PubMed ID: 14747559
[TBL] [Abstract][Full Text] [Related]
32. Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks.
Cheung RC; Trujillo DE; Robinson WS; Greenberg HB; Marion PL
Virology; 1990 Jun; 176(2):546-52. PubMed ID: 1693247
[TBL] [Abstract][Full Text] [Related]
33. [Establishment of a method to detect duck hepatitis B virus covalently closed circular DNA based on rolling circle amplification].
Su HL; Wang HM; Ran JY; Wang Z; Li HY; Yang Y; Xu DP; Liu YM
Bing Du Xue Bao; 2014 Jul; 30(4):382-6. PubMed ID: 25272590
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the kinetics of the specific cellular immune response to duck hepatitis B virus in infected and immune ducks.
Vickery K; Cossart Y; Dixon R
Vet Microbiol; 1999 Aug; 68(1-2):157-69. PubMed ID: 10501173
[TBL] [Abstract][Full Text] [Related]
35. [Research on the gene structure of duck hepatitis B virus and its encoding proteins].
Liu Q; Jia RY
Bing Du Xue Bao; 2012 Nov; 28(6):681-8. PubMed ID: 23367570
[TBL] [Abstract][Full Text] [Related]
36. The effect of surgical immunomodulation on liver inflammation and clearance of DHBV infection.
Vickery K; Tohidi-Esfahani R; Pouliopoulos J; Welschinger R; Dixon R; Deva A; Cossart Y
J Med Virol; 2006 Dec; 78(12):1572-8. PubMed ID: 17063509
[TBL] [Abstract][Full Text] [Related]
37. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
38. The early host innate immune response to duck hepatitis B virus infection.
Tohidi-Esfahani R; Vickery K; Cossart Y
J Gen Virol; 2010 Feb; 91(Pt 2):509-20. PubMed ID: 19846670
[TBL] [Abstract][Full Text] [Related]
39. Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
Lenhoff RJ; Luscombe CA; Summers J
Hepatology; 1999 Feb; 29(2):563-71. PubMed ID: 9918936
[TBL] [Abstract][Full Text] [Related]
40. Cellular immune response of ducks to duck hepatitis B virus infection.
Vickery K; Cossart Y; Dixon R
J Med Virol; 1999 May; 58(1):19-25. PubMed ID: 10223541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
